An interactive family forum on global warming and a series of hands-on science activities for children and families were featured at Ithaca's Sciencenter Feb. 17. (Feb. 20, 2007)
President David Skorton prioritized faculty renewal in his State of the University Address June 9 during Reunion Weekend. He also announced that the naming of the new humanities building that will break ground in 2013.
New York state has awarded a $1 million grant to NewYork-Presbyterian Hospital to help fund the construction of a clean and efficient cogeneration plant and help lower the hospital's energy costs.
As high school seniors anxiously await the mailman each spring with hopes for an admission letter from a college or university of their choice, an offer from Cornell would qualify as a dream come true, according to findings from this year's Princeton Review survey of colleges. (March 28, 2006)
Cornell University President Elizabeth Garrett died March 6 from colon cancer. She was 52. "There are few words to express the enormity of this loss," said Robert S. Harrison, chairman of the Cornell Board of Trustees.
The last few years have been trying for the financial industry, said banker and philanthropist Sanford Weill '55, but with strong leadership and smarter regulation, signs point toward a steady recovery. (June 12, 2010)
A special 10-foot sound cube will be in the Kenneth Goldman Lounge of the Duffield Hall atrium Thursday, March 30, from 11 a.m. to 1 p.m., offering a unique, multichannel immersive sound environment.
The MorrowSound Cube, a 3-D…
Cornell President David Skorton announced that $25 million from the family of John Dyson '65 will establish a new school - the Charles H. Dyson School of Applied Economics and Management. (June 8, 2010)
Milton Curry '88 looks back on his six years as director of the Cornell Council for the Arts and says he sees more opportunities for interdisciplinary intellectual engagement among faculty and students. (July 23, 2008)
Previous attempts in mice to correct a rare inherited immune disorder, called Hyper IgM X-linked immunodeficiency, have failed because standard gene therapy raised risks for cancer. Now Weill Cornell Medical College researchers believe they've found a way around that problem.